Clinical Trial Update: Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older [Phase 2]

View source ↗

Summary

A Phase 2 trial update evaluating the safety and immunogenicity of CRV-101 vaccine for preventing herpes zoster in adults aged 50 and older. The study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• CRV-101

Snippet

Sponsor: Curevo Inc | Conditions: Herpes Zoster, Shingles | Phase 2 | Status: ACTIVE_NOT_RECRUITING